Don’t miss the latest developments in business and finance.

Gen-Next's stock wealth rises to Rs 17k cr in market rally

This includes value of shares owned by the children of top executives and promoters of listed blue-chips such as Infosys, Cipla, Sun Pharma and the Reliance groups

Press Trust of India New Delhi
Last Updated : Nov 02 2014 | 11:57 AM IST
As record stock market rally continues, the value of shares directly owned by next-generation business leaders at 20 major corporate houses has soared over 18% to Rs 17,000 crore so far this year.

This includes value of shares owned by the children of top executives and promoters of the listed blue-chips such as Infosys, Cipla, Sun Pharma and the Reliance groups, while excluding the family holdings and equity owned through other entities such as trusts.

Collectively, the value of their holdings has risen by Rs 2,600 crore (18.2%), from about Rs 14,000 crore at the end of 2013.

Also Read

Topping the charts, the children of Infosys founders saw the value of their combined shareholding soar by 14% to Rs 12,200 crore in the first 10 months this year. The total value of their combined shareholding had soared by over 50% to Rs 10,720 crore during 2013.

Among them, Akshata Murthy and Rohan Murty saw the value of their shares top the Rs 6,500 crore mark. Similarly, the value of shares allotted to former Infosys CEO Nandan Nilekani's children Nihar and Jahnavi rose to nearly Rs 1,350 crore, as an analysis of data available on the BSE.

The next-generation of other Infosys co-promoters like Meghana (Kris Gopalakrishnan), Divya & Deeksha (K Dinesh), Shruti and Shreyas (S D Shibulal) saw their holdings rise to Rs 245 crore, Rs 1,115 crore and Rs 2,978 crore respectively.

Value of holdings of Wipro Chairman Azim Premji's sons Rishad and Tariq, however, at Rs 53.6 crore saw marginal rise as shares of the IT major were flat from last year-end.

Among other notable winners, Aalok Shanghvi, son of Sun Pharma founder Dilip Shanghvi, and his sister Vidhi's combined kitty rode on the back of over 46 per cent uptick in the drug maker's stock price to touch about Rs 485 crore. Aalok is senior general manager of international business at the firm.

There has also been robust rise in wealth of children of Cipla's M K Hameid, Kamil and Samina as value of holdings soared by Rs 550 crore. In 2013, gains were marginal. Siblings Kamil, who is chief strategy officer of Cipla, and Samina hold shares worth about Rs 1,390 crore.

Sons of Wockhardt promoter Habil Khorakiwala -- Murtaza (Managing Director) and Huzaifa (Executive Director) -- saw 75% rise in holdings at Rs 34 crore.

More From This Section

First Published: Nov 02 2014 | 11:35 AM IST

Next Story